Sign in

CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company

Personalis, Inc.

Sign in to watch
Ticker
PSNL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275411038
Phone
650-752-1300
Business address
6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$728,924
in 5 filings

Net −$728,924. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-06-16 Chen Richard Chief Medical Officer and EVP Sale −4,817 $2.07 $10K 125,529
2023-06-16 Tachibana Aaron CFO and COO Sale −6,904 $2.07 $14K 193,990
2023-06-13 WIDDER KENNETH J Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2023-05-17 MYERS WOODROW A JR Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-05-17 Bloom Olivia Kyusuk Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-05-17 EASTHAM KARIN Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-05-17 Shoff Lonnie Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-05-17 Colowick Alan Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-05-17 BOWMAN A BLAINE Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-05-17 Tachibana Aaron CFO and COO Sale −1,389 $1.98 $3K 200,894
2023-05-17 Moore Stephen Michael General Counsel Sale −1,781 $1.98 $4K 81,627
2023-05-17 Chen Richard Chief Medical Officer and EVP Sale −971 $1.98 $2K 130,346
2023-05-02 Moore Stephen Michael General Counsel Sale −5,102 $2.29 $12K 83,408
2023-03-17 Tachibana Aaron CFO and COO Sale −3,945 $2.83 $11K 202,283
2023-03-17 Chen Richard Chief Medical Officer and EVP Sale −1,314 $2.83 $4K 131,317
2023-03-15 Moore Stephen Michael General Counsel Grant or award · Stock Option (right to buy) +40,000 40,000
2023-03-15 Chen Richard Chief Medical Officer and EVP Grant or award · Stock Option (right to buy) +250,000 250,000
2023-03-15 Tachibana Aaron CFO and COO Grant or award · Stock Option (right to buy) +450,000 450,000
2023-03-15 Hall Christopher M President and CEO Grant or award · Stock Option (right to buy) +400,000 400,000
2023-01-31 Tachibana Aaron Chief Financial Officer Sale −767 $2.20 $2K 206,228

Page 8 of 23 · 444 trades